Telix Pharmaceuticals Limited

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Telix Pharmaceuticals Limited
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Australia
Headquarters city: North Melbourne
Headquarters country: Australia
Fiscal year end: December
Ticker symbol: TLX
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0002007191

Board of directors

Follow this board

Christian Behrenbruch · Director · MD & Group CEO
Since 2026
David N. Gill · Director
Since 2026
Jann Elizabeth Skinner · Director
Since 2026
Maria Rivas · Director
Since 2026
Marie Elizabeth McDonald · Director
Since 2026
Mark Alexander Nelson · Director
Since 2026
William R. Jellison · Director
Since 2026

Chief executives

Christian Behrenbruch · MD & Group CEO

Since March 2026

Board connections

3 of this board's directors also sit on 5 other boards. 4 are in the same sector.

Shared director Other board Same sector

Anika Therapeutics Inc. Same sector
via William R. Jellison
Avient Corporation
via William R. Jellison
Evolus Inc. Same sector
via David N. Gill
Medtronic plc. Same sector
via William R. Jellison
The Cooper Companies Inc. Same sector
via Maria Rivas

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $1,016,744; 3 purchases by 2 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Sep 7, 2026	Smith Darren Charlton Officer (Group Chief Financial Officer)	Open-market purchase	+2,071	$9.66	$20,006
Apr 29, 2026	Christian Behrenbruch Director, Officer (MD & Group CEO)	Open-market purchase	+33,435	$14.87	$497,178
Apr 28, 2026	Christian Behrenbruch Director, Officer (MD & Group CEO)	Open-market purchase	+34,500	$14.48	$499,560
Mar 29, 2026	Smith Darren Charlton Officer (Group Chief Financial Officer)	Option exercise	+1,111	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

Alterity Therapeutics Limited Nasdaq: ATHE · Melbourne, Australia Organization 3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization AC Immune SA Nasdaq: ACIU · 1015 Lausanne, Switzerland Organization

Questions about Telix Pharmaceuticals Limited

Who is the CEO of Telix Pharmaceuticals Limited?

Christian Behrenbruch has been Telix Pharmaceuticals Limited's MD & Group CEO since March 2026.

How many directors are on Telix Pharmaceuticals Limited's board?

Telix Pharmaceuticals Limited's board has 7 directors: Christian Behrenbruch, David N. Gill, Jann Elizabeth Skinner, Maria Rivas, Marie Elizabeth McDonald, Mark Alexander Nelson and William R. Jellison.

Are Telix Pharmaceuticals Limited insiders buying or selling shares?

Over the last 12 months, Telix Pharmaceuticals Limited insiders bought $1.0 million of shares in 3 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Telix Pharmaceuticals Limited connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="telix-pharmaceuticals-limited"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.